Mesirow Institutional Investment Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-213,980
Closed -$16.2M – 135
2023
Q4
$16.2M Buy
213,980
+41,558
+24% +$2.63M 1.51% 13
2023
Q3
$11.4M Buy
172,422
+2,241
+1% +$168K 1.15% 38
2023
Q2
$13.8M Sell
170,181
-47,534
-22% -$3.38M 1.43% 12
2023
Q1
$12.9M Buy
217,715
+39,875
+22% +$2.22M 1.4% 2
2022
Q4
$8.68M Sell
177,840
-18,655
-9% -$862K 1.14% 40
2022
Q3
$10.1M Buy
+196,495
New +$11.7M 1.47% 20

Other funds holding THC

Mesirow Institutional Investment Management's THC Position: Q1 2024 in Review

Mesirow Institutional Investment Management sold out of Tenet Healthcare (THC) in Q1 2024, closing a stake of 213,980 shares — an estimated $16.2M sold.

Mesirow Institutional Investment Management first reported a position in THC in Q3 2022 and held it in 6 quarters. The position peaked at $16.2M in Q4 2023. 459 funds tracked by Wall St. Rank hold THC as of Q1 2024.

  • Mesirow Institutional Investment Management reported no remaining Tenet Healthcare position as of Q1 2024 after selling out during the quarter.
  • Mesirow Institutional Investment Management sold 213,980 Tenet Healthcare shares in Q1 2024, an estimated $16.2M.
  • Mesirow Institutional Investment Management first reported a position in Tenet Healthcare in Q3 2022 and held it in 6 quarters.
  • Mesirow Institutional Investment Management's Tenet Healthcare position peaked at $16.2M in Q4 2023.
  • 459 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q1 2024, filed 6 May 2024.